Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 49

Results For "Global"

4792 News Found

Concept Medical unveils landmark SirPAD trial at ACC 2026, advancing PAD treatment
Medical Device | April 03, 2026

Concept Medical unveils landmark SirPAD trial at ACC 2026, advancing PAD treatment

The SirPAD trial marks a significant milestone in vascular intervention, positioning MagicTouch PTA as a promising future alternative for PAD treatment


Sahyadri Hospital brings first non-surgical treatment for severe knee pain to Maharashtra
Hospitals | April 03, 2026

Sahyadri Hospital brings first non-surgical treatment for severe knee pain to Maharashtra

Low-dose radiotherapy offers immediate pain relief, quicker recovery, and better movement through a non-invasive procedure


Merck secures landmark EU nod for KEYTRUDA in hard-to-treat ovarian cancer
News | April 03, 2026

Merck secures landmark EU nod for KEYTRUDA in hard-to-treat ovarian cancer

Its a major breakthrough for women’s ovarian cancer care in Europe


India’s bioeconomy hits $165.7 billion as govt unveils fresh biopharma push
Biotech | April 03, 2026

India’s bioeconomy hits $165.7 billion as govt unveils fresh biopharma push

DBT-BIRAC, BioE3 and the Rs 10,000-crore Biopharma SHAKTI scheme aim to accelerate innovation, biomanufacturing and exports


Biocytogen and Sihuan Pharmaceutical forge strategic pact to accelerate antibody-based therapies
R&D | April 03, 2026

Biocytogen and Sihuan Pharmaceutical forge strategic pact to accelerate antibody-based therapies

The agreement will combine Biocytogen’s cutting-edge fully human antibody discovery platform with Sihuan Pharmaceutical’s extensive drug development


Cardinal Health boosts production of cutting-edge cancer therapy ingredient
News | April 03, 2026

Cardinal Health boosts production of cutting-edge cancer therapy ingredient

Ac-225, an alpha-emitting radionuclide, can be paired with molecules designed to selectively target cancer cells.


BioE3 policy accelerates India’s biomanufacturing ambitions with biofoundries, AI hubs & space biotech
Policy | April 03, 2026

BioE3 policy accelerates India’s biomanufacturing ambitions with biofoundries, AI hubs & space biotech

Government outlines advanced shared infrastructure and DBT-ICGEB biofoundry expansion to fast-track lab-to-market innovation across six strategic biotech sectors


Saharsh Davuluri takes over as CEO & MD of Neuland  Laboratories
Appointment | April 02, 2026

Saharsh Davuluri takes over as CEO & MD of Neuland Laboratories

18-year veteran Saharsh will position the CDMO as a premier global API process development and commercial manufacturing specialist


Molbio’s digital radiology arm secures CE MDR certification for its medical imaging portfolio
Medical Device | April 02, 2026

Molbio’s digital radiology arm secures CE MDR certification for its medical imaging portfolio

Certification by TÜV SÜD Product Service GmbH reinforces the company's commitment to globally benchmarked standards in safety, quality, and performance


Alembic Pharmaceuticals partners with Enthral.ai for learning and training management of its 9000+ learners
News | April 02, 2026

Alembic Pharmaceuticals partners with Enthral.ai for learning and training management of its 9000+ learners

Enthral.ai’s platform integrates AI-driven capabilities with compliance-first architecture, enabling automated training workflows